Tanja Jovanovic Selected Research

Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder)

3/2022	A randomized controlled trial of 3,4-methylenedioxymethamphetamine (MDMA) and fear extinction retention in healthy adults.
1/2022	Remodeling of the Cortical Structural Connectome in Posttraumatic Stress Disorder: Results From the ENIGMA-PGC Posttraumatic Stress Disorder Consortium.
1/2022	Acquisition, extinction, and return of fear in veterans in intensive outpatient prolonged exposure therapy: A fear-potentiated startle study.
12/2021	The Enduring Importance of Parenting: Caregiving Quality and Fear-Potentiated Startle in Emerging Adults With a Child Maltreatment History.
11/2021	An intensive outpatient program with prolonged exposure for veterans with posttraumatic stress disorder: Retention, predictors, and patterns of change.
11/2021	Development and Validation of a Model to Predict Posttraumatic Stress Disorder and Major Depression After a Motor Vehicle Collision.
11/2021	A prospective examination of sex differences in posttraumatic autonomic functioning.
10/2021	Emotion dysregulation and dissociation contribute to decreased heart rate variability to an acute psychosocial stressor in trauma-exposed Black women.
9/2021	Acupuncture for combat post-traumatic stress disorder: trial development and methodological approach for a randomized controlled clinical trial.
1/2021	Prognostic neuroimaging biomarkers of trauma-related psychopathology: resting-state fMRI shortly after trauma predicts future PTSD and depression symptoms in the AURORA study.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tanja Jovanovic Research Topics

Disease

71	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 03/2022 - 03/2010
27	Wounds and Injuries (Trauma) 02/2022 - 01/2009
8	Mental Disorders (Mental Disorder) 07/2020 - 02/2012
4	Inflammation (Inflammations) 02/2022 - 01/2016
4	Anxiety Disorders (Anxiety Disorder) 07/2020 - 09/2013
3	Schizophrenia (Dementia Praecox) 10/2019 - 12/2006
3	Infections 01/2019 - 07/2010
2	Syndrome (Syndromes) 01/2015 - 10/2011
2	Neoplasms (Cancer) 04/2012 - 02/2009
1	Type 2 Diabetes Mellitus (MODY) 02/2022
1	Sexual Trauma 01/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 11/2021
1	Anhedonia 01/2021
1	Periapical Periodontitis (Apical Periodontitis) 03/2020
1	Necrosis 03/2020
1	Bone Resorption 03/2020
1	Bradycardia 01/2020
1	Epilepsy (Aura) 01/2020
1	Temporal Lobe Epilepsy 01/2020
1	Autonomic Nervous System Diseases (Dysautonomia) 01/2020
1	Seizures (Absence Seizure) 01/2020
1	Parkinson Disease (Parkinson's Disease) 10/2019
1	Bipolar Disorder (Manic Depressive Psychosis) 10/2019
1	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2018
1	Cysts 03/2017
1	Panic Disorder (Panic Attack) 01/2017
1	Social Phobia 01/2017
1	Psychotic Disorders (Schizoaffective Disorder) 01/2017
1	Agoraphobia 01/2017
1	Phobic Disorders (Phobia) 01/2017
1	Major Depressive Disorder (Major Depressive Disorders) 01/2016

Drug/Important Bio-Agent (IBA)

35	Biomarkers (Surrogate Marker)IBA 02/2022 - 01/2009
12	Biological ProductsIBA 11/2021 - 02/2012
6	Hydrocortisone (Cortisol)FDA LinkGeneric 11/2021 - 11/2011
5	Messenger RNA (mRNA)IBA 01/2021 - 01/2017
5	Cycloserine (Seromycin)FDA Link 12/2019 - 06/2014
4	Estrogens (Estrogen)FDA Link 09/2017 - 07/2012
3	Hormones (Hormone)IBA 01/2022 - 01/2015
3	CytokinesIBA 03/2020 - 10/2014
3	Dexamethasone (Maxidex)FDA LinkGeneric 01/2019 - 11/2011
3	Indicators and Reagents (Reagents)IBA 01/2018 - 10/2014
3	C-Reactive ProteinIBA 01/2017 - 04/2015
3	Catechol O-Methyltransferase (Methyltransferase, Catechol)IBA 01/2016 - 01/2013
2	N-Methyl-3,4-methylenedioxyamphetamine (MDMA)IBA 03/2022 - 10/2017
2	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2013
2	HLA-DPB1 antigen (HLA DPB1)IBA 01/2021 - 10/2019
2	Corticotropin-Releasing Hormone Receptors (Corticotropin Releasing-Hormone Receptor)IBA 01/2020 - 06/2014
2	GlucocorticoidsIBA 01/2020 - 01/2019
2	NBI 77860IBA 01/2020 - 06/2014
2	Corticotropin-Releasing HormoneIBA 01/2020 - 06/2014
2	Immunoglobulin G (IgG)IBA 12/2019 - 01/2019
2	Pharmaceutical PreparationsIBA 01/2019 - 05/2007
2	Biological FactorsIBA 09/2017 - 06/2010
2	Alprazolam (Xanax)FDA LinkGeneric 01/2016 - 06/2014
2	CatecholaminesIBA 01/2015 - 01/2015
2	valylvaline (Val-Val)IBA 10/2014 - 01/2013
2	methionylmethionine (Met-Met)IBA 10/2014 - 01/2013
2	Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP)IBA 02/2014 - 02/2011
2	Opioid Analgesics (Opioids)IBA 06/2013 - 10/2011
2	DNA (Deoxyribonucleic Acid)IBA 01/2013 - 04/2012
2	Antipsychotic Agents (Antipsychotics)IBA 03/2011 - 12/2006
1	Interleukin-6 (Interleukin 6)IBA 02/2022
1	Keratins (Keratin)IBA 01/2022
1	Environmental BiomarkersIBA 01/2022
1	ProteomeIBA 01/2022
1	Mitochondrial DNA (mtDNA)IBA 01/2022
1	3,4-methylenedioxyethamphetamine (MDEA)IBA 11/2021
1	Glutamic Acid (Glutamate)FDA Link 01/2021
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2021
1	Guanosine Triphosphate (GTP)IBA 01/2021
1	OsteoprotegerinIBA 03/2020
1	Interleukin-1beta (Interleukin 1 beta)IBA 03/2020
1	LigandsIBA 03/2020
1	Vesicular Monoamine Transport Proteins (Vesicular Monoamine Transporter)IBA 01/2020
1	Pregnanolone (Allopregnanolone)IBA 01/2020
1	Polysaccharides (Glycans)IBA 12/2019
1	Nootropic Agents (Nootropics)IBA 12/2019
1	Dopamine (Intropin)FDA LinkGeneric 10/2019
1	HLA-A Antigens (HLA-A)IBA 10/2019
1	HLA-DQA1 antigen (HLA DQA1)IBA 10/2019
1	HLA-DQB1 antigen (HLA DQB1)IBA 10/2019
1	HLA Antigens (Human Leukocyte Antigens)IBA 10/2019
1	HLA-B Antigens (HLA-B)IBA 10/2019
1	HLA-C Antigens (HLA-C)IBA 10/2019
1	HLA-DRB1 Chains (HLA DRB1)IBA 10/2019
1	ChitinasesIBA 01/2019
1	Transcription Factors (Transcription Factor)IBA 01/2019
1	Small Interfering RNA (siRNA)IBA 01/2019
1	Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA 01/2018
1	EpitopesIBA 03/2017
1	Antidepressive Agents (Antidepressants)IBA 01/2017
1	Gonadal HormonesIBA 08/2015

Therapy/Procedure

9	Therapeutics 01/2022 - 02/2009
2	Drug Therapy (Chemotherapy) 01/2020 - 02/2009
1	Glycemic Control 02/2022
1	Apicoectomy 03/2020
1	Lasers (Laser) 01/2020
1	Laser Therapy (Surgery, Laser) 01/2020
1	Smart Glasses 12/2019
1	Precision Medicine 01/2019